Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
5.4. Pricing Analysis
Chapter 6. Global Poultry Vaccines Market, by Diseases
6.1. Introduction
6.2. Infectious bronchitis
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3. Avian Influenza
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4. Marek's Disease
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.5. Newcastle Disease
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.6. Others
Chapter 7. Global Poultry Vaccines Market, by Technology
7.1. Introduction
7.2. Toxoid Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.3. Recombinant Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.4. Inactivated Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.5. Live Attenuated Vaccines (LAV)
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.6. Others
Chapter 8. Global Poultry Vaccines Market, by Dosage Form
8.1. Introduction
8.2. Duct Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.3. Liquid Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.4. Freeze Dried Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.5. Others
Chapter 9. Global Poultry Vaccines Market, by Region
9.1. Introduction
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
Chapter 10. Company Landscape
10.1. Introduction
10.2. Market Share Analysis
10.3. Key Developments & Strategies
Chapter 11. Company Profiles
11.1. Boehringer Ingelheim GmbH
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financials Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Elanco
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financials Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. MSD & Co.
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financials Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Zoetis Inc
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financials Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Ceva Animal Health Inc.
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financials Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Phibro Animal Health Corporation
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financials Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Virbac
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financials Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Hipra
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financials Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Venkys
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financials Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Biovet
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financials Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Anicon GmbH
11.11.1. Company Overview
11.11.2. Product Overview
11.11.3. Financials Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Others
Chapter 12. MRFR Conclusion
12.1. Key Findings
12.1.1. From CEO’s View point
12.1.2. Unmet Needs of the Market
12.2. Key Companies to Watch
12.3. Predictions for the Poultry Vaccines Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1. Global Poultry Vaccines Market Synopsis, 2023-2032
Table 2. Global Poultry Vaccines Market Estimates and Forecast, 2023-2032 (USD Million)
Table 3. Global Poultry Vaccines Market, by Region, 2023-2032 (USD Million)
Table 4. Global Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 5. Global Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 6. Global Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 7. North America: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 8. North America: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 9. North America: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 10. US: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 11. US: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 12. US: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 13. Canada: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 14. Canada: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 15. Canada: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 16. Latin America: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 17. Latin America: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 18. Latin America: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 19. Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 20. Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 21. Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 22. Western Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 23. Western Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 24. Western Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 25. Eastern Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 26. Eastern Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 27. Eastern Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 28. Asia-Pacific: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 29. Asia-Pacific: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 30. Asia-Pacific: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 31. Middle East & Africa: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 32. Middle East & Africa: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 33. Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Poultry Vaccines Market
Figure 3. Segmentation Market Dynamics for Global Poultry Vaccines Market
Figure 4. Global Poultry Vaccines Market Share, by Diseases, 2020
Figure 5. Global Poultry Vaccines Market Share, by Technology, 2020
Figure 6. Global Poultry Vaccines Market Share, by Dosage Form, 2020
Figure 7. Global Poultry Vaccines Market Share, by Region, 2020
Figure 8. North America: Poultry Vaccines Market Share, by Country, 2020
Figure 9. Europe: Poultry Vaccines Market Share, by Country, 2020
Figure 10. Asia-Pacific: Poultry Vaccines Market Share, by Country, 2020
Figure 11. Middle East & Africa: Poultry Vaccines Market Share, by Country, 2020
Figure 12. Global Poultry Vaccines Market: Company Share Analysis, 2020 (%)
Figure 13. Boehringer Ingelheim GmbH: Key Financials
Figure 14. Boehringer Ingelheim GmbH: Segmental Revenue
Figure 15. Boehringer Ingelheim GmbH: Geographical Revenue
Figure 16. Elanco: Key Financials
Figure 17. Elanco: Segmental Revenue
Figure 18. Elanco: Geographical Revenue
Figure 19. MSD & Co.: Key Financials
Figure 20. MSD & Co.: Segmental Revenue
Figure 21. MSD & Co.: Geographical Revenue
Figure 22. Zoetis: Key Financials
Figure 23. Zoetis: Segmental Revenue
Figure 24. Zoetis: Geographical Revenue
Figure 25. Ceva Animal Health Inc.: Key Financials
Figure 26. Ceva Animal Health Inc.: Segmental Revenue
Figure 27. Ceva Animal Health Inc.: Geographical Revenue
Figure 28. Phibro Animal Health Corporation: Key Financials
Figure 29. Phibro Animal Health Corporation: Segmental Revenue
Figure 30. Phibro Animal Health Corporation: Geographical Revenue
Figure 31. Virbac: Key Financials
Figure 32. Virbac: Segmental Revenue
Figure 33. Virbac: Geographical Revenue
Figure 34. Hipra: Key Financials
Figure 35. Hipra: Segmental Revenue
Figure 36. Hipra: Geographical Revenue
Figure 37. Venkys: Key Financials
Figure 38. Venkys: Segmental Revenue
Figure 39. Venkys: Geographical Revenue
Figure 40. Biovet: Key Financials
Figure 41. Biovet: Segmental Revenue
Figure 42. Biovet: Geographical Revenue
Figure 43. Anicon GmbH: Key Financials
Figure 44. Anicon GmbH: Segmental Revenue
Figure 45. Anicon GmbH: Geographical Revenue